Skip to main content
. Author manuscript; available in PMC: 2015 Dec 1.
Published in final edited form as: Clin Cancer Res. 2014 Oct 7;20(23):5946–5955. doi: 10.1158/1078-0432.CCR-14-1404

Table 2.

Immunohistochemistry

Patient ID Reovirus RNA Reovirus protein p38 Caspase-3 Cycle of treatment
A 36% 9% 94% 1% 8
B 100% 14% 78% ND 2
C 100% 11% 98% 0.3% 1
D 100% 3% 19% 1% 1
G 40% 1% 45% 0% 1
H 100% 0% 99% ND 4
I 20% ND ND ND 5

Immunohistochemical analysis of 7 evaluable patient samples; co-expression analyses included CD138+, reoviral RNA, capsid protein, p38, and caspase-3. Abbreviations: Reovirus RNA = reoviral RNA/CD138+ cells post-treatment; Reovirus protein = reoviral protein/CD138+ cells post-treatment; p38/CD138+ = p38 pre-treatment cells; caspase-3 = caspase-3 post-treatment.